IBOV 174,576.80 ▲ 1.55% IPSA 11,450.75 ▼ 0.76% IPC MEX 65,522.56 ▼ 0.38% MERVAL 3,009,029 ▲ 0.46% COLCAP 2,508.47 ▼ 0.09% BVL PERÚ 60,117.56 ▲ 0.55% USD/BRL5.15▼ 0.12% USD/MXN16.94▼ 0.04% USD/CLP911.95▼ 0.10% USD/COP3,084▲ 1.30% USD/PEN3.35▼ 0.08% USD/ARS1,512▲ 0.13% USD/UYU40.18▲ 1.06% USD/PYG5,968▲ 0.82% USD/BOB11.47▲ 0.68% USD/DOP58.01▲ 0.07% USD/CRC447.25▲ 0.82% USD/GTQ7.62▲ 2.02% USD/HNL26.82▲ 1.52% USD/NIO36.62▲ 0.09% USD/VES785.55▲ 0.19% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.73▲ 0.97% EUR/BRL6.00▲ 0.15% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 174,576.80 ▲ 1.55% IPSA 11,450.75 ▼ 0.76% IPC MEX 65,522.56 ▼ 0.38% MERVAL 3,009,029 ▲ 0.46% COLCAP 2,508.47 ▼ 0.09% BVL PERÚ 60,117.56 ▲ 0.55% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Wednesday, August 26, 2026

Peru declares health emergency in response to rise in Guillain-Barré syndrome cases

By · July 8, 2023 · 2 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

Peru has announced a national health emergency for a period of 90 days due to a concerning surge in Guillain Barré Syndrome (GBS) cases.

The declaration aims to ensure an adequate supply of pharmaceutical products, enhance disease surveillance and research efforts, and improve patient care within healthcare services.

The official decree, published in the Official Gazette El Peruano, also emphasizes the need to strengthen the control of GBS cases, develop educational materials for public and healthcare personnel, and focus on prevention, preparedness, and effective management of the syndrome.

Peru declares health emergency in response to rise in Guillain-Barré syndrome cases. (Photo Internet reproduction)
Peru declares health emergency in response to rise in Guillain-Barré syndrome cases. (Photo Internet reproduction)
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →
RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

Acute bacterial or viral infections typically trigger Guillain-Barré syndrome.

The syndrome has also been isolated in the context of mRna vaccination (Covid) as one of the main side effects, along with myocarditis.

It manifests through symptoms such as weakness and tingling in the feet and legs, which can progress to affect the upper body and, in severe cases, lead to paralysis.

According to the National Center for Epidemiology, Disease Prevention and Control, as of June 23, 2023, there have been 103 reported cases of the syndrome this year.

The average monthly number of cases nationwide remains below 20, which is lower than the figures observed in previous years, particularly during the 2019 outbreak.

However, an uptick in cases has been observed since the end of June, with 16 reported cases compared to the earlier average range of 2 to 8 cases per week.

Recognizing the potential impact on the availability of immunoglobulin, a crucial treatment for GBS, Peru’s Minister of Health, César Vásquez Sánchez, urged the declaration of a sanitary emergency.

The purpose is to expedite acquiring and distributing the necessary immunoglobulin supplies to meet the growing demand.

“We have requested the declaration of a health emergency for Guillain-Barré syndrome in order to secure adequate immunoglobulin supplies.”

“If the number of cases continues to rise, there is a risk of shortage.”

“Our priority is to ensure the availability of treatment for the population,” stated Minister Sánchez after the Council of Ministers meeting, as the official Andina news agency reported.

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.